Macerich (NYSE:MAC - Get Free Report) had its price objective raised by research analysts at Compass Point from $20.00 to $23.00 in a note issued to investors on Thursday,Benzinga reports. The firm currently has a "buy" rating on the real estate investment trust's stock. Compass Point's price objective suggests a potential upside of 20.99% from the company's previous close.
MAC has been the topic of several other research reports. The Goldman Sachs Group boosted their price target on Macerich from $13.00 to $14.60 and gave the stock a "sell" rating in a research note on Thursday, September 19th. Piper Sandler upped their price target on Macerich from $11.00 to $14.00 and gave the stock an "underweight" rating in a report on Tuesday, September 3rd. Evercore ISI boosted their target price on Macerich from $15.00 to $16.00 and gave the stock an "in-line" rating in a report on Wednesday, August 28th. StockNews.com upgraded shares of Macerich from a "sell" rating to a "hold" rating in a research report on Friday, August 2nd. Finally, Bank of America upped their price target on shares of Macerich from $17.00 to $19.00 and gave the company a "neutral" rating in a research note on Friday, October 11th. Four equities research analysts have rated the stock with a sell rating, five have issued a hold rating and one has issued a buy rating to the company. Based on data from MarketBeat, Macerich currently has an average rating of "Hold" and an average price target of $16.40.
Read Our Latest Stock Analysis on MAC
Macerich Stock Performance
Shares of Macerich stock traded up $0.40 during trading hours on Thursday, hitting $19.01. 643,906 shares of the company were exchanged, compared to its average volume of 1,770,883. The business has a 50-day moving average of $17.48 and a 200-day moving average of $16.00. The stock has a market capitalization of $4.11 billion, a price-to-earnings ratio of -57.60, a P/E/G ratio of 0.62 and a beta of 2.50. The company has a current ratio of 0.86, a quick ratio of 0.86 and a debt-to-equity ratio of 1.76. Macerich has a 1 year low of $9.90 and a 1 year high of $20.27.
Institutional Inflows and Outflows
Several institutional investors have recently modified their holdings of MAC. Metis Global Partners LLC lifted its stake in shares of Macerich by 31.1% in the third quarter. Metis Global Partners LLC now owns 22,242 shares of the real estate investment trust's stock worth $406,000 after acquiring an additional 5,280 shares in the last quarter. Victory Capital Management Inc. grew its position in Macerich by 7.7% in the third quarter. Victory Capital Management Inc. now owns 89,058 shares of the real estate investment trust's stock worth $1,624,000 after acquiring an additional 6,346 shares in the last quarter. Versor Investments LP bought a new position in shares of Macerich in the third quarter worth about $516,000. Assetmark Inc. lifted its stake in shares of Macerich by 5.6% in the third quarter. Assetmark Inc. now owns 18,404 shares of the real estate investment trust's stock valued at $336,000 after buying an additional 971 shares during the period. Finally, Van ECK Associates Corp increased its stake in Macerich by 12.3% in the third quarter. Van ECK Associates Corp now owns 37,235 shares of the real estate investment trust's stock valued at $681,000 after acquiring an additional 4,086 shares during the period. 87.38% of the stock is currently owned by institutional investors and hedge funds.
About Macerich
(
Get Free Report)
Macerich is a fully integrated, self-managed and self-administered real estate investment trust (REIT). As a leading owner, operator and developer of high-quality retail real estate in densely populated and attractive U.S. markets, Macerich's portfolio is concentrated in California, the Pacific Northwest, Phoenix/Scottsdale, and the Metro New York to Washington, DC corridor.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Macerich, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Macerich wasn't on the list.
While Macerich currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.